Add-On Sequential Triple Combination Therapy for Pulmonary Arterial Hypertension Not at Goal

被引：0
|
作者：
Deshwal, H. [1 ]
Weinstein, T. [1 ]
Klapholz, J. [2 ]
Cefali, F. [1 ]
Fenton, R. [1 ]
Bondarsky, E. [1 ]
Sulica, R. [1 ]
机构：
[1] NYU, Grossman Sch Med, Div Pulm Crit Care & Sleep Med, New York, NY USA
[2] NYU, Grossman Sch Med, New York, NY USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3054
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Long-term impact of add-on sequential triple combination therapy in pulmonary arterial hypertension: real world experience
    Deshwal, Himanshu
    Weinstein, Tatiana
    Salyer, Rachel
    Thompson, Jesse
    Cefali, Frank
    Fenton, Rebecca
    Bondarsky, Eric
    Sulica, Roxana
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2023, 17
  • [2] Intravenous treprostinil as an add-on therapy in patients with pulmonary arterial hypertension
    Olsson, Karen M.
    Richter, Manuel J.
    Kamp, Jan C.
    Gall, Henning
    Heine, Alexander
    Ghofrani, Hossein-Ardeshir
    Fuge, Jan
    Ewert, Ralf
    Hoeper, Marius M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (07): : 748 - 756
  • [3] Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension
    Fernandes, Caio J. C. S.
    da Silva, Taysa A. F.
    Alves Jr, Jose L.
    Jardim, Carlos V. P.
    de Souza, Rogerio
    [J]. PULMONARY CIRCULATION, 2021, 11 (01)
  • [4] Triple therapy with saxagliptin and dapagliflozin add-on to metformin: safety of dual add-on versus sequential add-on
    Garcia-Sanchez, R.
    Del Prato, S.
    Matthaei, S.
    Iqbal, N.
    Hansen, L.
    Johnsson, E.
    Chen, H.
    Chin, A. J.
    Mathieu, C.
    [J]. DIABETOLOGIA, 2015, 58 : S356 - S356
  • [5] Add-on parenteral therapy in pulmonary arterial hypertension: The good, the bad, and the ugly
    Schoenberg, Noah C.
    Farber, Harrison W.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (09): : 1003 - 1005
  • [6] Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension
    Ivy, D. Dunbar
    Feinstein, Jeffrey A.
    Yung, Delphine
    Mullen, Mary P.
    Kirkpatrick, Edward C.
    Hirsch, Russel
    Austin, Eric D.
    Fineman, Jeffrey
    Truong, Uyen
    Solum, Derek
    Deng, C. Q.
    Hopper, Rachel K.
    [J]. PULMONARY CIRCULATION, 2019, 9 (03)
  • [7] Sequential combination therapy in pulmonary arterial hypertension (PAH)
    Keogh, A.
    Kotlyar, E.
    Macdonald, P.
    Hayward, C.
    Corrigan, C.
    Pidoux, A.
    Brown, K.
    Williams, T.
    Gabbay, E.
    McNeil, K.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S186 - S186
  • [8] Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension
    Channick, Richard N.
    Olschewski, Horst
    Seeger, Werner
    Staub, Ted
    Voswinckel, Robert
    Rubin, Lewis J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (07) : 1433 - 1437
  • [9] Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension
    Channick, RN
    Olschewski, H
    Seeger, W
    Staub, T
    Rubin, LJ
    [J]. CIRCULATION, 2005, 112 (17) : U566 - U566
  • [10] Inhaled iloprost as an add-on therapy for advanced pulmonary arterial hypertension: An Indian perspective
    Bobhate, Prashant
    Gupta, Rajat Kumar
    Karande, Tanuja
    Kulkarni, Snehal
    [J]. NATIONAL MEDICAL JOURNAL OF INDIA, 2022, 35 (06): : 338 - 343
12345